Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR0187) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Bencyclane
|
|||||
Synonyms |
BENCYCLANE; Benciclano; Benciclano [INN-Spanish]; Bencyclan; Bencyclane (INN); Bencyclane [INN]; Bencyclanum; Bencyclanum [INN-Latin]; Benzcyclan; benzcyclane; 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)cycloheptyl)oxy)-; 1-Propanamine, N,N-dimethyl-3-[[1-(phenylmethyl)cycloheptyl]oxy]-; 2179-37-5; 3-((1-Benzylcycloheptyl)oxy)-N,N-dimethylpropylamin; 6I97Z6S135; AC1L1DE9; AC1Q58XJ; C19H31NO; CHEMBL2110767; DSSTox_CID_2646; DSSTox_GSID_22646; DSSTox_RID_97536; DTXSID0022646; EINECS 218-547-0; SCHEMBL64881; UNII-6I97Z6S135
|
|||||
Indication | Cerebral vasospasm [ICD11: BA85] | Investigative | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 289.5 | Topological Polar Surface Area | 12.5 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 7 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
Cross-matching ID | ||||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||||||||||||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.